Articles tagged "marginal"

2016 American Transplant Congress
The UKKDRI Score Predicts Outcomes of Deceased Donor Transplantation Using a Steroid Sparing Immunosuppressive Protocol.
A. Wardle, M. Willicombe, D. Goodall, A. McLean, D. Taube.
Imperial College REnal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
The UK kidney donor risk-index (UKKDRI) was developed to provide a simplistic clinical tool to help determine quality of an allograft and aid informed consent.…
2016 American Transplant Congress
A Users Guide to Maximizing Utility and Outcome in >70 Year Old Donors.
K. Halazun, E. Przybyszewski, B. Samstein, E. Verna, A. Fox, R. Brown, J. Emond.
Liver Transplant & HPB Surgery, Weill Cornell Medical College, NY, NY.
Background Among 10 million stroke fatalities in the US since 2002, donated livers were recovered from 28,313. Unfortunately, only 2,402 livers were yielded from 7.5…
2016 American Transplant Congress
Validation of the Newly Developed North America Islet Donor Scoring System in the Medium Volume Islet Transplant Center.
J. Solomina,¹ S. Matosz,¹ M. Sledzinski,² J. Golebiewska,³ O. Savaril,¹ L.-J. Wang,⁴ T. Kin,⁵ K. Golab,¹ S. Ramachandran,¹ M. Tibudan,¹ L. Schenck,¹ W. Chon,⁶ C. Thomas,⁶ P. Witkowski.¹
¹Surgery, University of Chicago, Chicago, IL; ²Surgery, Medical University of Gdansk, Gdansk, Poland; ³Internal Medicine, Medical University of Gdansk, Gdansk, Poland; ⁴Surgery, University of Illinois, Chicago, IL; ⁵Surgery, University of Alberta, Edmonton, AB, Canada; ⁶Medicine, University of Chicago, Chicago, IL.
Background.North America Islet Donor Scoring (NAIDS) system has been recently developed for selection of the optimal pancreas donor based on analysis of the results from…
2016 American Transplant Congress
A Call for a New Paradigm of Organ Allocation within the Confines of MELD for Those Who Are Not “the Sickest”.
T. Baker, A. Siarris, P. Accoh, D. Ladner.
Comprehensive Transplant Center, Northwestern University, Chicago, IL.
BACKGROUND: Liver Allocation policy in the United States is in dynamic flux, with revisions in policy reflecting designs to optimize access to and outcomes for…
2016 American Transplant Congress
Relative Distribution of Livers from HCV+ Donors in the U.S.
J. Salazar,¹ J. Roberts,¹ N. Mehta,¹ M. Volk,² J. Lai.¹
¹University of California, San Francisco, San Francisco; ²Loma Linda University, Loma Linda.
Background: HCV-antibody positive donors represent an effective strategy to increase liver availability to HCV+ recipients. However, many HCV+ liver transplant (LT) candidates are now receiving…
2016 American Transplant Congress
Does Location Matter for Withdrawal of Donation After Cardiac Death Donors ?
K. Mekeel,¹ W. Garrison,² J. Trageser,² J. Berumen,¹ L. Stocks,² A. Hemming.¹
¹Surgery, University of California-San Diego, La Jolla, CA; ²Lifesharing, San Diego, CA.
Purpose: Withdrawal for DCD donors traditionally occurs in the OR. Families often refuse to proceed with DCD donation if they are unable to be present…
2016 American Transplant Congress
Resolution of Donor Non-Alcoholic Fatty Liver Disease Following Liver Transplantation.
A. Posner,¹ W. Twaddell,² S. Hanish,² D. Bruno,² W. Hutson,² L. Hebert,² R. Barth,² J. LaMattina.²
¹University of Maryland School of Medicine, Baltimore, MD; ²Division of Transplantation, University of Maryland School of Medicine, Baltimore, MD.
Purpose: Severe and moderate degrees of donor liver steatosis have traditionally limited the transplantation of these organs. The natural history of successfully transplanted livers with…
2016 American Transplant Congress
Activated Cytoprotective Mechanisms in DBD Kidneys Correlate with Kidney Function in Transplant Recipients: A Study Using Clinical Samples from the UK QUOD Biobank.
M. Kaisar,¹ L. van Dullemen,² Z. Akhtar,¹ M. Lo Faro,¹ H. Huang,¹ H. Leuvenink,² B. Kessler,¹ R. Ploeg.¹
¹Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom; ²UMCG, UMCG, Groningen, Netherlands.
The onset of abnormal pathophysiological changes following brain death adversely impact kidney function following transplantation. Understanding the biological mechanisms that affect kidney quality will allow…
2016 American Transplant Congress
Understanding the Initial Rise in Kidney Discard Rates Observed Post-KAS.
D. Stewart,¹ A. Kucheryavaya,¹ R. Brown,¹ D. Klassen,¹ N. Turgeon,² M. Aeder.³
¹UNOS, Richmond, VA; ²Emory Univ, Atlanta, GA; ³Univ Hosp Case Med Ctr, Cleveland, OH.
Background: Kidney discard rates increased by 10% -- from 18.3% to 20.2% (p=0.001) -- during the first 7 months of KAS but returned to pre-KAS…
2016 American Transplant Congress
Is Donor Methamphetamine Use a Contraindication in Heart Transplantation?
M. Kittleson, J. Patel, L. Czer, A. Velleca, T. Aintablian, D. Chang, F. Esmailian, J. Kobashigawa.
Cedars-Sinai Heart Institute, Los Angeles, CA.
Background: Donor methamphetamine (meth) use has been a relative contraindication for the use of the donor hearts for patients awaiting heart transplantation. The concern is…